ThomasChasMeriganMD(He/Him)

Grant Support

• Management Of Hepatitis C Virus (HCV) And HIV-1 Co-Infected SubjectsNational Center For Research Resources2007
• A5132 Trial To Evaluate Interleukin-2 (Il-2) Potent Antiretroviral TherapyNational Center For Research Resources2007
• Determine Time To Development Of AIDS Defining Complications &InfectionsNational Center For Research Resources2005–2007
• Study On Ability To Enhance Hiv-Specific Immune ResponsesNational Center For Research Resources2005–2006
• HIV Subjects With Decreased Bone Mineral Density Receiving Calcium And Vitamin DNational Center For Research Resources2005–2006
• Antiviral Management Of Hepatitis C Virus And HIV-1 Co-Infected SubjectsNational Center For Research Resources2005–2006
• Virologic Studies In Compartmental Samples From Hiv-Infected SubjectsNational Center For Research Resources2005
• Trial Of Valganciclovir ACTG 5030 AIDS StudyNational Center For Research Resources2005
• Treatment Of Elevated Non-Hdl Cholesterol And Elevated Triglycerides In HIVNational Center For Research Resources2005
• Ribavirin On Zidovudine Or Stavudine Triphosphate Formation A5092s In AIDSNational Center For Research Resources2005
• Pulse Therapy On The Characteristics Of Treatment Interruptions AIDSNational Center For Research Resources2005
• Protease Inhibitor-Sparing Regimens For The Initial Treatment Of HIV InfectionNational Center For Research Resources2005
• HIV Subjects With Failure Of Previous Protease Inhibitor-Based RegimensNational Center For Research Resources2005
• Gene Construct In The Treatment Of Patients With HIV-1 InfectionNational Center For Research Resources2005
• ACTG 5001 Adult AIDS Clinical Trials Group Longitudinal Linked RandomizedNational Center For Research Resources2004–2005
• Virologic Studies In Compartmental Samples For HIVNational Center For Research Resources2004
• Prolongation Of Virologic SuccessNational Center For Research Resources2004
• Phase I/II Random, Double-Blind, Placebo-Control StudyNational Center For Research Resources2004
• Pharmacokinetic Interaction Study: Amprenavir, EfavirenzNational Center For Research Resources2004
• Pharmacokinetic Evaluation Of The Effects Of RibavirinNational Center For Research Resources2004
• Determine Time To Development Of AIDS Defining InfectionNational Center For Research Resources2004
• Combinations Of Potent Antiretroviral TherapyNational Center For Research Resources2004
• ACTG 5095 Phase III, Randomized, Double-Blind Comparison Of Three ProteaseNational Center For Research Resources2004
• A5170 Predictors Of Immunologic And Clinical Progression In Subjects With CD4+National Center For Research Resources2004
• A5163 A Phase II, Randomized, Double-Blind StudyNational Center For Research Resources2004
• A5148 A Pilot Study Of The Safety And Efficacy Of NiacinNational Center For Research Resources2004
• A5146 A Randomized Controlled TrialNational Center For Research Resources2004
• A5142 A Phase III Randomized, Open-Label ComparisonNational Center For Research Resources2004
• A5132 An Exploratory, Open-Label, Randomized TrialNational Center For Research Resources2004
• A5126 A Phase II Study Of The Predictive ValueNational Center For Research Resources2004
• A5102 An Open-Label, Pilot Study Utilizing CD4+ T-CellsNational Center For Research Resources2004
• A Randomized, Double-Blind, Placebo-Controlled StudyNational Center For Research Resources2004
• A Randomized Phase II, Double-Blind, Controlled TrialNational Center For Research Resources2004
• A Phase III, Prospective, Randomized, Double-Blind Trial Of Valganciclovir P...National Center For Research Resources2004
• AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1988–2003
• High Protein Supplement In HIV With Stable Weight LossNational Center For Research Resources2000–2001
• Antiviral Activity Of T 1249 In HIV-1 InfectionNational Center For Research Resources2000–2001
• Antiretroviral Therapy For HIV W/ Nelfinavir FailureNational Center For Research Resources2000–2001
• Amprenavir For HIV Multi Drug ResistanceNational Center For Research Resources2000–2001
• Clinical Trials Adoptive Cell TransferNational Institute Of Allergy And Infectious Diseases1997
• HIV Specific Allogeneic Cellular ImmunotherapyNational Institute Of Allergy And Infectious Diseases1994–1997
• Adult AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
• Interferon Immunity And Latent VirusesNational Institute Of Allergy And Infectious Diseases1993–1995
• AIDS Research CenterNational Institute Of Allergy And Infectious Diseases1994
• Infectious Diseases Training - Microbes, Drugs And HostNational Institute Of Allergy And Infectious Diseases1985–1994
• Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1993
• AIDS Research Center Core Support GrantNational Institute Of Allergy And Infectious Diseases1988–1993
• Murine Retroviral Model For HIV Drug EvaluationNational Institute Of Allergy And Infectious Diseases1990–1992
• Interferon, Immunity, And Latent VirusesNational Institute Of Allergy And Infectious Diseases1989–1992
• Antigen Presenting Vehicles In HSV And HIV InfectionsNational Institute Of Allergy And Infectious Diseases1989–1991
• Interferon, Immunity And Latent VirusesNational Institute Of Allergy And Infectious Diseases1988
• Infectious Diseases--Microbes, Drugs, And HostNational Institute Of Allergy And Infectious Diseases1988
• Interferon, Immunity And Latent VirusesNational Institute Of Allergy And Infectious Diseases1985–1987
• Clinical &Laboratory Studies Of Interferon In LymphomaNational Cancer Institute1985–1986